165 results
DEFA14A
wbbxuksfyoy43
9 Feb 24
Additional proxy soliciting materials
9:00am
DEFM14A
i08cyyv18z 5kc9je43g
18 Jan 24
Proxy related to merger
7:44am
PRER14A
4abjsnsi1ltgr rr
18 Jan 24
Preliminary revised proxy
7:19am
PREM14A
oouci1lkhq45 8h711
5 Jan 24
Preliminary proxy related to merger
5:13pm
DEFA14A
itwi675xty 6wq
7 Dec 23
Additional proxy soliciting materials
8:02am
8-K
EX-2.1
d16n80pfwddty
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-10.1
8e6w68c0z86355aqfqbr
7 Dec 23
AbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
8:00am
8-K
EX-1.1
js9649
12 Oct 23
Cerevel Therapeutics Announces Proposed Public Offering of Common Stock
4:19pm
424B5
xrdrbw4uvnvo32p
12 Oct 23
Prospectus supplement for primary offering
4:16pm
8-K
75d uowqnuu
11 Oct 23
Results of Operations and Financial Condition
4:14pm
424B5
zxt pxxh53q6icr
11 Oct 23
Prospectus supplement for primary offering
4:08pm
8-K
m2ln4zy6
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:29pm